Literature DB >> 27034274

Duchenne Muscular Dystrophy Mice and Men: Can Understanding a Genetic Cardiomyopathy Inform Treatment of Other Myocardial Diseases?

Jill A Rafael-Fortney1, Jessica A Chadwick2, Subha V Raman2.   

Abstract

Entities:  

Keywords:  cardiomyopathy; claudin-5; dystrophin; heart; mineralocorticoid receptor

Mesh：

Substances：

Year:  2016        PMID： 27034274      PMCID： PMC4819164          DOI： 10.1161/CIRCRESAHA.116.308402

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  18 in total

1.  Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.

Authors:  J A Rafael; J M Tinsley; A C Potter; A E Deconinck; K E Davies
Journal:  Nat Genet       Date:  1998-05       Impact factor: 38.330

2.  Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients.

Authors:  Tsuyoshi Matsumura; Toshio Saito; Harutoshi Fujimura; Susumu Shinno
Journal:  Brain Dev       Date:  2007-03-21       Impact factor: 1.961

3.  Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.

Authors:  Jill A Rafael-Fortney; Neeraj S Chimanji; Kevin E Schill; Christopher D Martin; Jason D Murray; Ranjit Ganguly; Jenna E Stangland; Tam Tran; Ying Xu; Benjamin D Canan; Tessily A Mays; Dawn A Delfín; Paul M L Janssen; Subha V Raman
Journal:  Circulation       Date:  2011-07-18       Impact factor: 29.690

4.  Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model.

Authors:  Dawn A Delfín; Ying Xu; Kevin E Schill; Tessily A Mays; Benjamin D Canan; Kara E Zang; Jamie A Barnum; Paul M L Janssen; Jill A Rafael-Fortney
Journal:  Mol Ther       Date:  2012-05-01       Impact factor: 11.454

5.  Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.

Authors:  Paul M L Janssen; Nitisha Hiranandani; Tessily A Mays; Jill A Rafael-Fortney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-07-15       Impact factor: 4.733

6.  Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature.

Authors:  T A Hainsey; S Senapati; D E Kuhn; J A Rafael
Journal:  Neuromuscul Disord       Date:  2003-05       Impact factor: 4.296

7.  Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.

Authors:  Dawn A Delfín; Kara E Zang; Kevin E Schill; Nikita T Patel; Paul M L Janssen; Subha V Raman; Jill A Rafael-Fortney
Journal:  Neuromuscul Disord       Date:  2012-06-29       Impact factor: 4.296

8.  Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.

Authors:  Kan N Hor; Janaka Wansapura; Larry W Markham; Wojciech Mazur; Linda H Cripe; Robert Fleck; D Woodrow Benson; William M Gottliebson
Journal:  J Am Coll Cardiol       Date:  2009-04-07       Impact factor: 24.094

9.  Claudin-5 levels are reduced in human end-stage cardiomyopathy.

Authors:  Tessily A Mays; Philip F Binkley; Amanda Lesinski; Amit A Doshi; Michael P Quaile; Kenneth B Margulies; Paul M L Janssen; Jill A Rafael-Fortney
Journal:  J Mol Cell Cardiol       Date:  2008-04-25       Impact factor: 5.000

10.  Distinct Aspects of Left Ventricular Mechanical Function Are Differentially Associated With Cardiovascular Outcomes and All-Cause Mortality in the Community.

Authors:  Susan Cheng; Elizabeth L McCabe; Martin G Larson; Allison A Merz; Ewa Osypiuk; Birgitta T Lehman; Plamen Stantchev; Jayashri Aragam; Scott D Solomon; Emelia J Benjamin; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2015-10-27       Impact factor: 5.501
View more
  8 in total

1.  rAAVrh74.MCK.GALGT2 Protects against Loss of Hemodynamic Function in the Aging mdx Mouse Heart.

Authors:  Rui Xu; Ying Jia; Deborah A Zygmunt; Paul T Martin
Journal:  Mol Ther       Date:  2019-01-15       Impact factor: 11.454

2.  Acute AT1R blockade prevents isoproterenol-induced injury in mdx hearts.

Authors:  Tatyana A Meyers; Jackie A Heitzman; Aimee M Krebsbach; Lauren M Aufdembrink; Robert Hughes; Alessandro Bartolomucci; DeWayne Townsend
Journal:  J Mol Cell Cardiol       Date:  2019-01-19       Impact factor: 5.000

3.  Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes.

Authors:  Hideki Yasutake; Jong-Kook Lee; Akihito Hashimoto; Kiyoshi Masuyama; Jun Li; Yuki Kuramoto; Shuichiro Higo; Shungo Hikoso; Kyoko Hidaka; Atsuhiko T Naito; Shigeru Miyagawa; Yoshiki Sawa; Issei Komuro; Yasushi Sakata
Journal:  Sci Rep       Date:  2021-05-14       Impact factor: 4.379

Review 4.  Cardiac Pathophysiology and the Future of Cardiac Therapies in Duchenne Muscular Dystrophy.

Authors:  Tatyana A Meyers; DeWayne Townsend
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923

5.  Mineralocorticoid Receptor Signaling Contributes to Normal Muscle Repair After Acute Injury.

Authors:  J Spencer Hauck; Zachary M Howard; Jeovanna Lowe; Neha Rastogi; Madison G Pico; Sarah A Swager; Jennifer M Petrosino; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Federica Accornero; Jill A Rafael-Fortney
Journal:  Front Physiol       Date:  2019-10-25       Impact factor: 4.566

6.  Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial.

Authors:  Subha V Raman; Kan N Hor; Wojciech Mazur; Xin He; John T Kissel; Suzanne Smart; Beth McCarthy; Sharon L Roble; Linda H Cripe
Journal:  Orphanet J Rare Dis       Date:  2017-02-20       Impact factor: 4.303

7.  Stabilization of Early Duchenne Cardiomyopathy With Aldosterone Inhibition: Results of the Multicenter AIDMD Trial.

Authors:  Subha V Raman; Kan N Hor; Wojciech Mazur; Andrea Cardona; Xin He; Nancy Halnon; Larry Markham; Jonathan H Soslow; Michael D Puchalski; Scott R Auerbach; Uyen Truong; Suzanne Smart; Beth McCarthy; Ibrahim M Saeed; Jeffrey M Statland; John T Kissel; Linda H Cripe
Journal:  J Am Heart Assoc       Date:  2019-09-24       Impact factor: 5.501

8.  Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future.

Authors:  Agnieszka Łoboda; Józef Dulak
Journal:  Pharmacol Rep       Date:  2020-07-20       Impact factor: 3.024
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.